Applied Tumor Genomics Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Oncogene. 2021 Sep;40(36):5533-5547. doi: 10.1038/s41388-021-01940-0. Epub 2021 Jul 23.
Cancer is the most complex genetic disease known, with mutations implicated in more than 250 genes. However, it is still elusive which specific mutations found in human patients lead to tumorigenesis. Here we show that a combination of oncogenes that is characteristic of liver cancer (CTNNB1, TERT, MYC) induces senescence in human fibroblasts and primary hepatocytes. However, reprogramming fibroblasts to a liver progenitor fate, induced hepatocytes (iHeps), makes them sensitive to transformation by the same oncogenes. The transformed iHeps are highly proliferative, tumorigenic in nude mice, and bear gene expression signatures of liver cancer. These results show that tumorigenesis is triggered by a combination of three elements: the set of driver mutations, the cellular lineage, and the state of differentiation of the cells along the lineage. Our results provide direct support for the role of cell identity as a key determinant in transformation and establish a paradigm for studying the dynamic role of oncogenic drivers in human tumorigenesis.
癌症是已知的最复杂的遗传性疾病,有超过 250 个基因的突变与癌症相关。然而,仍然难以确定在人类患者中发现的哪些特定突变会导致肿瘤发生。在这里,我们表明,肝癌中特有的一组癌基因(CTNNB1、TERT、MYC)组合会诱导人成纤维细胞和原代肝细胞衰老。然而,将成纤维细胞重编程为肝祖细胞命运,诱导的肝细胞(iHeps)使它们对相同的癌基因转化敏感。转化的 iHeps 具有高度增殖性,在裸鼠中致瘤,并具有肝癌的基因表达特征。这些结果表明,肿瘤发生是由三个因素的组合触发的:一组驱动突变、细胞谱系以及沿着谱系的细胞分化状态。我们的结果为细胞身份作为转化的关键决定因素提供了直接支持,并为研究致癌驱动因素在人类肿瘤发生中的动态作用建立了范例。